Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07IYO
|
|||
| Drug Name |
Triazavirin
|
|||
| Synonyms |
Riamilovir; Riamilovir [INN]; Triazavirin [WHO-DD]
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H4N6O3S
|
|||
| Canonical SMILES |
CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
|
|||
| InChI |
1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)
|
|||
| InChIKey |
IDVQGNMSSHPZSJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 123606-06-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A New Antiviral Drug Triazavirin: Results of Phase II Clinical Trial. Vopr Virusol. Nov-Dec 2012;57(6):9-12. | |||
| REF 2 | China Tests Russian Antiviral Drug Which Might Treat Coronavirus As Moscow Warns Of Possible Mass Outbreak. February 5, 2020 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.